Editorial comment on: new treatment approaches for prostate cancer based on peptide analogues.
Bamias
Aristotelis
A
Department of Clinical Therapeutics, Medical School, University of Athens, Athens, Greece. abamias@med.uoa.gr
Dimopoulos
Meletios A
MA
D000726:Androgen Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010455:Peptides / Q000627:therapeutic use*; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D013004:Somatostatin / Q000031:analogs & derivatives*; D016896:Treatment Outcome
D000726:Androgen Antagonists; D010455:Peptides; D013004:Somatostatin